西安地区癌症患者慢性癌症相关性疼痛现状及影响因素分析

doi:10.12183/j.scjpm.2023.0234

[1] 李小梅, 袁文茜, 曹伯旭, 等. 慢性癌症相关性疼痛[J]. 中国疼痛医学杂志, 2021, 27(3): 161-165.
[2] Swarm RA, Paice JA, Anghelescu DL, et al.Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(8): 977-1007.
[3] Neufeld NJ, Elnahal SM, Alvarez RH.Cancer pain: A review of epidemiology, clinical quality and value impact[J]. Future Oncol, 2017, 13(9): 833-841.
[4] Russo MM, Sundaramurthi RT.An overview of cancer pain: Epidemiology and pathophysiology[J]. Semin Oncol Nurs, 2019, 35(3):223-228.
[5] Gao W, Gulliford M, Bennett MI, et al.Managing cancer pain at the end of life with multiple strong opioids:A population-based retrospective cohort study in primary care[J]. PLoS One, 2014, 9(1): e79266.
[6] Zigmond AS, Snaith RP.The hospital anxiety and depression scale[J]. Acta Psychiatr Scand, 1983, 67(6): 361-370.
[7] Hjermstad MJ, Fayers PM, Haugen DF, et al.Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: A systematic literature review[J]. J Pain Symptom Manage, 2011, 41(6): 1073-1093.
[8] Bennett MI, Kaasa S, Barke A, et al.The IASP classification of chronic pain for ICD-11: Chronic cancer-related pain[J]. Pain, 2019, 160(1): 38-44.
[9] 国家中医药局办公室, 国家卫生健康委办公厅. 癌症疼痛诊疗规范(2018 年版)[J].全科医学临床与教育, 2019, 17(1):4-8.
[10] Zhang C, Xiao J, Yu Z, et al.Cancer pain management and the roles of pharmacists in China[J]. Int J Clin Pharm, 2021, 43(2): 383-385.
[11] Xu X, Luckett T, Wang AY, et al.Cancer pain management needs and perspectives of patients from Chinese backgrounds: A systematic review of the Chinese and English literature[J]. Palliat Support Care, 2018, 16(6): 785-799.
[12] Bingel U, Wanigasekera V, Wiech K, et al. The effect of treatment expectation on drug efficacy:Imaging the analgesic benefit of the opioid remifentanil[J]. Sci Transl Med, 2011, 3(70): 70ra14.
[13] 孙勇, 刘武, 张维, 等. 二甲双胍对2型糖尿病并发神经病理性疼痛大鼠的抗痛觉异常作用及机制研究[J]. 中华神经医学杂志, 2021, 20(12):1194-1203.
[14] Fink RM, Gallagher E.Cancer pain assessment and measurement[J]. Semin Oncol Nurs, 2019, 35(3): 229-234.
[15] Zebralla V, Wichmann G, Pirlich M, et al.Dysphagia, voice problems, and pain in head and neck cancer patients[J]. Eur Arch Otorhinolaryngol, 2021, 278(10): 3985-3994.
[16] 王琦, 张文胜. 癌性疼痛的研究进展[J]. 国际麻醉学与复苏杂志, 2019, 40(4):383-387.
[17] 王稳, 樊碧发. 癌痛发生机制的研究进展[J]. 中国疼痛医学杂志, 2021, 27(8):616-618.
[18] Blanton HL, Brelsfoard J, DeTurk N, et al. Cannabinoids: Current and future options to treat chronic and chemotherapy-induced neuropathic pain[J]. Drugs, 2019, 79(9): 969-995.
[19] Doo AR, Shin YS, Yoo S, et al.Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration[J]. J Pain Res, 2018, 11: 545.

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	YAN Chun, GONG Yuan, HUANG Ping, CHEN Juan, HUANG Miao. Early poor prognosis and predictive model construction in patients with acute ischemic stroke [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1213-1217.
[2]	XU Yan, WANG Xuexia, HAN Chunling. Characteristics and influencing factors of polypoid lesion of gallbladder in adult residents of Dongying City [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1224-1228.
[3]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1294-1297.
[4]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1305-1308.
[5]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1327-1329.
[6]	JING Leilei, WANG Yating, YANG Yong, LI Yajie, ZHAO Haiying, LI Huifang, LI Zhanpeng. Influencing factors of knee osteoarthritis in people ≥ 40 years old in Zhangjiakou area [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1078-1082.
[7]	WANG Shijian, CHEN Zelun, ZHENG Jingjing, XU Ying. Analysis of the incidence and influencing factors of retinopathy in elderly patients with hypertension [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1098-1102.
[8]	ZHAO Xiaohong, XU Shanshan, HAN Yuzhou, HUANG Haisha, SUN Jingjing. Status and influencing factors of adverse pregnancy outcomes in pregnant women with gestational diabetes mellitus in Langfang City [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1109-1113.
[9]	LI Nannan, HUANG Limin, ZHANG Xiaohua. Incidence and risk factors of major adverse cardiovascular events in patients with acute coronary syndrome within 1 year after discharge [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1119-1123.
[10]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1180-1183.
[11]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1188-1191.
[12]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1205-1208.
[13]	YAN Yongfeng, XU Yuanyou, WANG Jun, CHEN Yongsheng, ZHANG Yonghui, DING Lulu, CHEN Jianguo, FAN Jian, ZHU Jian. Trend analysis of brain tumor survival rate in Qidong City, Jiangsu Province, 1972 - 2016 [J]. South China Journal of Preventive Medicine, 2023, 49(8): 960-964.
[14]	LUO Chengli, LIU Fangjing, PENG Xiang, LI Shimei, WU Qiaohui, MAO Li, DONG Yuan, SUN Xianfu, LI Shuangle. Prevalence and influencing factors of cataract among the elderly in Zigong City [J]. South China Journal of Preventive Medicine, 2023, 49(8): 990-994.
[15]	FAN Hailong, NIU Yanbin, GUO Zhenshan, AN Qianjiang, WANG Xiumei. Association between visceral adiposity index and blood glucose variation in Chinese middle-aged and elderly prediabetic population： a cohort study [J]. South China Journal of Preventive Medicine, 2023, 49(7): 803-807.